Home › Compare › MENXF vs ABBV
MENXF yields 2000000.00% · ABBV yields 3.06%● Live data
📍 MENXF pulled ahead of the other in Year 1
Combined, MENXF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MENXF + ABBV for your $10,000?
Memex Inc. develops, commercializes, and manufactures a suite of products for its customers in the discrete manufacturing and aerospace sectors worldwide. The company primarily offers MERLIN Tempus, a software-driven industrial Internet of Things communications platform that provides manufacturing productivity metrics, including overall equipment effectiveness in real time. Its MERLIN Tempus measures and analyzes manufacturing and production performance, and provides its users with real-time insights on operational efficiency. The company also provides MERLIN Tempus Enterprise Edition for enhancing the value of time with enterprise resource planning connectivity and job scheduling; MERLIN financial Overall Equipment Effectiveness (FOEE), which enables factory organizations to link their shop floor performance to actual profit dollars; MERLIN Continuous Improvement (CI) Fast-track services, a nine-step implementation process; and MERLIN Operator Portal, a Windows based human machine interface (HMI) that provides operators with a live window into what information is being collected from the machines in real-time. In addition, the company provides MERLIN Enterprise Resource Planning connector, a bi-synchronous interface; MERLIN OPTime to assess, measure, identify, and optimize data-driven manufacturing; and SCANGun, a bar code scanner. Further, it offers IIoT hardware solutions, including MERLIN MTC-One that incorporate sensor-based process-driven data; MTConnect hardware adapter, which enables machine tool to communicate critical operational information using the MTConnect standard protocol; software adapters; and DNC memory upgrade products. Memex Inc. was founded in 1992 and is headquartered in Burlington, Canada.
Full MENXF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.